trending Market Intelligence /marketintelligence/en/news-insights/trending/n7k1y4q-f4gzm1b6kclqwq2 content esgSubNav
In This List

Stellar Biotechnologies regains Nasdaq compliance

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Stellar Biotechnologies regains Nasdaq compliance

Port Hueneme, Calif.-based Stellar Biotechnologies Inc. regained compliance with Nasdaq's $1 minimum bid listing requirement.

The Nasdaq stock market notified the biotechnology company that the closing bid price for Stellar's common shares had been at least $1 per share for a minimum of 10 consecutive business days — effectively complying with the requirement.